Physician profile
Gregory Michael Morgan
NPI 1174559983
$5,415.61
in general payments reported to CMS, 2019-2025
7 companies · $285 in 2025
The $285 reported for 2025 was more than what 82% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $59.61 · 2021: $603 · 2022: $933 · 2023: $2,276 · 2024: $548 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,314 · Food and Beverage: $1,233 · Entertainment: $500 · Gift: $63.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,313.54 |
| Food and Beverage | $1,232.58 |
| Entertainment | $500.00 |
| Gift | $63.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $3,587.76 | 2019-2024 | |
| Patterson Companies, INC. | $750.00 | 2023 | |
| Henry Schein, INC. | $411.62 | 2019 | |
| Straumann USA LLC | $336.51 | 2024-2025 | |
| A-Dec, INC. | $275.25 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $46.36 | 2019 | |
| Ultradent Products INC | $8.11 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.